Since the new fatal pneumonia was identified in December 2019 in Wuhan, China, the WHO declared the infection a health emergency of international concern. The novel ss-RNA ß-coronavirus (SARS-CoV-2) spreads through airborne and direct contagion; virulence is high in the elderly and in patients with diabetes, chronic pulmonary, cardiovascular and neoplastic diseases. SARS-CoV-2 ssRNA is recognized by intracellular Pattern Recognition Receptors (PRRs), which trigger NF-kB - the master regulator of inflammation - and Interferon Regulatory Factors (IRFs)1 .

"Toxic erythema" and eosinophilia associated to tocilizumab therapy in a COVID-19 patient / Sernicola, Alvise; Carnicelli, Giorgia; Di Fraia, M; Chello, Camilla; Furlan, C; Muharremi, R; Paolino, Giovanni; Grieco, Teresa. - In: JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY. - ISSN 0926-9959. - 12:(2020), pp. 1-3. [10.1111/jdv.16620]

"Toxic erythema" and eosinophilia associated to tocilizumab therapy in a COVID-19 patient

Sernicola, Alvise
Primo
;
Carnicelli, Giorgia
Secondo
;
Di Fraia, M;Chello, Camilla;Furlan, C;Muharremi, R;Paolino, Giovanni
Penultimo
;
Grieco, Teresa
Ultimo
2020

Abstract

Since the new fatal pneumonia was identified in December 2019 in Wuhan, China, the WHO declared the infection a health emergency of international concern. The novel ss-RNA ß-coronavirus (SARS-CoV-2) spreads through airborne and direct contagion; virulence is high in the elderly and in patients with diabetes, chronic pulmonary, cardiovascular and neoplastic diseases. SARS-CoV-2 ssRNA is recognized by intracellular Pattern Recognition Receptors (PRRs), which trigger NF-kB - the master regulator of inflammation - and Interferon Regulatory Factors (IRFs)1 .
2020
COVID-19; drug eruption; eosinophilia; tocilizumab
01 Pubblicazione su rivista::01f Lettera, Nota
"Toxic erythema" and eosinophilia associated to tocilizumab therapy in a COVID-19 patient / Sernicola, Alvise; Carnicelli, Giorgia; Di Fraia, M; Chello, Camilla; Furlan, C; Muharremi, R; Paolino, Giovanni; Grieco, Teresa. - In: JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY. - ISSN 0926-9959. - 12:(2020), pp. 1-3. [10.1111/jdv.16620]
File allegati a questo prodotto
File Dimensione Formato  
Sernicola_Toxic-erythema_2020_pp.pdf

accesso aperto

Note: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7272956/
Tipologia: Documento in Post-print (versione successiva alla peer review e accettata per la pubblicazione)
Licenza: Tutti i diritti riservati (All rights reserved)
Dimensione 3.24 MB
Formato Adobe PDF
3.24 MB Adobe PDF
Sernicola_Toxic-erythema_2020.pdf

solo gestori archivio

Note: https://onlinelibrary.wiley.com/doi/epdf/10.1111/jdv.16620
Tipologia: Versione editoriale (versione pubblicata con il layout dell'editore)
Licenza: Tutti i diritti riservati (All rights reserved)
Dimensione 236.58 kB
Formato Adobe PDF
236.58 kB Adobe PDF   Contatta l'autore

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/11573/1392775
Citazioni
  • ???jsp.display-item.citation.pmc??? 10
  • Scopus 14
  • ???jsp.display-item.citation.isi??? 12
social impact